GRANTS CORNER
Chandra Shekhar Bakshi, D.V.M., Ph.D., associate professor of pathology, microbiology and immunology, received a $47,801 grant from Veralox Therapeutics for "Development of New Inhibitors to Treat Inflammatory Damage of COVID-19."
Malik Bisserier, Ph.D., assistant professor of cell biology and anatomy and of physiology, received a $135,303 grant from the NIH for "Role of SIN3a in the Epigenetic Regulation of the Bone Morhogenetic Protein Receptor Type 2 in Pulmonary Arterial Hypertension."
Mitchell Cairo, M.D., professor of pediatrics, medicine, cell biology and anatomy and of pathology, microbiology and immunology, received a $533,615 grant from Celularity Iqvia for "Phase 1 Multi-Dose Study of Human Placental...NT Human Interleukin-2 (RHIL-2) in Adults with Primary or Secondary Acute Myeloid Leukemia (AML) in Morphologic Complete Remission with Minimal Residual Disease (MRD) or Relapsed/Refractory AML” and a $213,975 grant from Omeros for “A Retrospective Study to Determine the Outcomes of Pediatric Patients with High-Risk HSCT-TMA Patients Following Allogeneic Hematopoietic Stem Cell Transplantation (ALLO-HSCT)."
Daniel Cho, M.D., professor of medicine, received a $50,000 grant from NextCure for “Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of NC318 in Subjects with Advanced or Metastatic Solid Tumors.”
Sanveet Chugh, M.D., associate professor of medicine, received a $61,000 grant from Alexion Pharmaceuticals for "A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants Who Have Thrombotic Microangiopathy Associated With a Trigger."
Simon Hanft, M.D., associate professor of neurosurgery, received a $50,000 grant from Imvax for “Evaluation of Immunological Responses Against Glioblastoma (GBM) Tumors.”
Supriya Jain, M.D., clinical associate professor of pediatrics and of radiology, received a $75,520 grant from Johns Hopkins University for “A Data Science Approach to Identify and Manage Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection and Kawasaki Disease in Pediatric Patients."
Masashi Kai, M.D., clinical associate professor of surgery, received a $26,000 grant from TransMedics for “The Portable Organ Care System (OCS™) Heart for Resuscitation, Preservation and Assessment of Hearts from Donors after Circulatory Death Continued Access Protocol (OCS DCD Heart CAP).”
Igor Laskowski, M.D., associate professor of surgery, received a $145,605 grant from Bolton Medical for “Terumo Aortic /’Post-Approval Study of the TREO Abdominal Stent-Graft System (P190015) in Patients with Infrarenal Abdominal Aortic and Aorto-iliac Aneurysms.’”
Delong Liu, M.D., Ph.D., professor of medicine, received a $145,020 grant from LOXO Oncology for “A Phase 3 Open-Label, Randomized Study of LOXO-305 versus Investigator Choice of BTK Inhibitor in Patients with Previously Treated BTK Inhibitor Naive Mantle Cell Lymphoma LOXO-BTK-20019” and a $121,134 grant from LOXO Oncology for “A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib (LOXO-305) plus Venetoclax and Rituximab versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia LOXO-BTK-20022.”
Dana Mordue, Ph.D., associate professor of pathology, microbiology and immunology, received a $121,934 grant from Stony Brook School of Medicine for "Host Peripheral Blood Biomarkers to Diagnose Active Lyme Disease and Post-Treatment Lyme Disease Syndrome."
Seigo Nishida, M.D., clinical professor of surgery, received a $121,695 grant from CareDX for “Molecular Assessment and Profiling of Liver Transplant Recipients: The Maple Study.”
Lance Parton, M.D., professor of pediatrics, associate professor of anesthesiology and of obstetrics and gynecology, received a $50,000 grant from Chiesi Pharmaceutical for "An Open-Label, Multicenter, Randomized, Controlled Study in Spontaneously Breathing Preterm Neonates with Respiratory Distress Syndrome to Compare Two Procedures for Porcine Surfactant (Poractant Alfa, Curosurf®) Administration: A Less Invasive Method (LISA) During Non-Invasive Ventilation (NIV) and the Conventional Administration During Brief Invasive Ventilation.”
Boriana Parvez, M.D., clinical professor of pediatrics, received a $50,000 grant from Ferring Pharmaceuticals for a “Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial Exploring the Efficacy and Safety of Intra-Nasal Administration of Merotocin in Increasing Milk Production in Maternal Subjects with Preterm Delivery and Inadequate Milk Production - MERMAID (Merotocin In Mothers With Inadequate Milk Production And Infants Delivered Prematurely).”
Karen Seiter, M.D., professor of medicine, received a $24,949 grant from Sellas Life Sciences for “A Randomized, Open-Label Study of the Efficacy and Safety of Galinpepimut-S (GPS) Maintenance Monotherapy Compared to Investigator's Choice of Best Available Therapy in Subjects with Acute Myeloid Leukemia Who Have Achieved Complete Remission After Second-Line Salvage Therapy.”
Libor Velisek, M.D., Ph.D., professor of cell biology and anatomy, pediatrics and of neurology, received a $44,342 grant from Equilibre Biopharmaceuticals B.V. for "Equilibre Biopharmaceuticals Compound EQU-001 for Treatment of Infantile Spasms.”
John Welter, M.D., assistant professor of pediatrics, received a $145,202 grant from Nabriva Therapeutics for “A Phase 1, Open-Label, Randomized, Crossover Study to Assess the Safety and Pharmacokinetics Following Single Doses of Oral and Intravenous Xenleta (Lefamulin) in Adult Patients with Cystic Fibrosis.”
Steven Wolf, M.D., clinical professor of pediatrics, received a $133,906 grant from SK Life Sciences, Inc. for "Open Label Safety and Efficacy Study of Cenobamate (YKP3089) in Pediatric Subjects with Partial Onset (Focal) Seizures" and a $96,822 grant from Noema Pharma for “A Phase 2B, Multicenter, 30-week, Prospective, Cross-over, Doubleblind, Randomized, Placebo-controlled Study Followed by a 52-Week Open-label Extension Study to Evaluate the Efficacy and Safety of Basimglurant Adjunctive to Ongoing Anticonvulsive Therapy in Children and Adolescents with Uncontrolled Seizures Associated with Tuberous Sclerosis Complex.”
Gary Wormser, M.D., professor of medicine, pharmacology and of pathology, microbiology and immunology, received a $6,500 grant from Biopeptides for "Development of a Cytokine Release Assay for the Diagnosis of Lyme Disease.”
|